C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2006
05/23/2006	US7049084 Neuroblastoma cell lines expressing the α2δ subunit of calcium channels and methods therefore
05/23/2006	US7049083 Methods for identifying modulators of N-type ion channel inactivation
05/23/2006	US7049080 Process for detecting serine/threonine kinase activity
05/23/2006	US7049078 Apolipoprotein E polymorphism and treatment of alzheimer's disease
05/23/2006	US7049077 Multiplexed nucleic acid analysis by fragmentation of double-stranded DNA
05/23/2006	US7049076 Method for assaying protein—protein interaction
05/23/2006	US7049075 Deoxyribonuclease IIβ proteins and cDNAs
05/23/2006	US7049074 Methods and compositions for the manipulation and characterization of individual nucleic acid molecules
05/23/2006	US7049073 Using phosphoramidite compound; biosynthesis
05/23/2006	US7049072 Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
05/23/2006	US7049071 Nucletide sequences coding protein for use as diagnostic tool in the detection of genetic damage
05/23/2006	US7049070 Detecting variation in nucleotide sequence pattern; obtain nucleotide squences, depolymerize, separate sequences, monitor mobility pattern of nucleotide sequences
05/23/2006	US7049069 Detection of urogenital disorders in humans; obtain biological sample, monitor cytokine expression, compare to wild type control, evaluate for urogenital disorders
05/23/2006	US7049068 Screening sample for annealed nucleotide sequences; obtain sample of nucleotide sequences, incubate with probes and transition metal comples, detect oxidation reduction reactions, detect annealed nucleotide sequences
05/23/2006	US7049067 Human immunodeficiency virus (HIV); which can bind to a specific site of the RNA; amplification; change in fluorescence upon hybridization
05/23/2006	US7049066 Diagnosis and treatment of myocardial failure
05/23/2006	US7049065 Method of preparing normalized and/or subtracted cDNA
05/23/2006	US7049064 Generating preferential microoarrays; obtain solid support, incubate with chemical intermediates, recover microarray
05/23/2006	US7049063 Lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides.
05/23/2006	US7049062 Assay for methylation in the GST-Pi gene
05/23/2006	US7049061 use of R-2,4-diaminobutyric acid as a replacement for gamma-aminobutyric acid to make the hairpin loop; bind to the minor groove of a promoter region of a DNA sequence; tighter binding of the polyamides to the minor groove of DNA and also provides an amine function for derivatizing
05/23/2006	US7049060 Secreted by hybridoma cell lines; hepatitis C virus (HCV)
05/23/2006	US7049059 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression
05/23/2006	US7049058 Methods for suppressing the induction of nitric oxide synthase in a cell
05/23/2006	US7048931 polypeptide with prostate-specific proteins, immunogenic portions or a T cell that is specific for cells expressing such a protein
05/23/2006	US7048930 Expression of core-glycosylated HCV envelope proteins in yeast
05/23/2006	US7048901 production method of the electrical connection structure, and electric wiring; carbon nanotube as the electrode and contacting the electrode with the biopolymer (DNA, RNA, or a protein) then applying an electric current between the electrode and biopolymer
05/23/2006	US7048890 magnetic detection of binding of biological molecules on a biochip in which a magnetoresistive sensor device measures an areal density of magnetic nanoparticles on a micro-array, the magnetic nanoparticles being directly or indirectly coupled to a target sample
05/23/2006	CA2335305C A bioluminescence resonance energy transfer (bret) system and its use
05/23/2006	CA2245514C Fractionation using dielectrophoresis and field flow fractionation
05/23/2006	CA2201865C Laminin chains: diagnostic and therapeutic use
05/20/2006	CA2527167A1 Nucleic acid preparation
05/18/2006	WO2006053322A2 Compositions and methods for inferring an adverse effect in response to a drug treatment
05/18/2006	WO2006053246A2 A new sos 1 gene from halophila that confers salt tolerance
05/18/2006	WO2006053187A2 Device and method for purification of biological materials
05/18/2006	WO2006053061A2 Porcine reproductive and respiratory syndrome virus receptor components and uses thereof
05/18/2006	WO2006052911A2 Laforin expression in diagnosis and treatment of cancer and other diseases
05/18/2006	WO2006052891A1 Analyte identification using electronic devices
05/18/2006	WO2006052862A1 Predicting response to chemotherapy using gene expression markers
05/18/2006	WO2006052857A2 Biomarker for heart failure
05/18/2006	WO2006052852A2 Kit for in process quality control to predict and determine engraftment and multilineage reconstitution potential of hematopoietic cells and cord blood storage
05/18/2006	WO2006052823A2 Biomarkers for prostate cancer metastasis
05/18/2006	WO2006052813A2 Stable and filterable enveloped virus formulations
05/18/2006	WO2006052746A2 Method of identifying compounds for bacterial growth modulation
05/18/2006	WO2006052735A2 Fibulin-3 and uses thereof
05/18/2006	WO2006052680A1 Compositions and methods for purifying nucleic acids from stabilization reagents
05/18/2006	WO2006052652A2 Rotary cam valve
05/18/2006	WO2006052302A2 Method of producing and purifying adenoviral vectors
05/18/2006	WO2006052218A1 Methods, systems, and arrays based on correlating p53 status with gene expression profiles, for classification, prognosis, and diagnosis of cancers
05/18/2006	WO2006051991A1 Method of amplifying and detecting nucleic acid
05/18/2006	WO2006051990A1 Diagnostic method using nucleic acid amplification
05/18/2006	WO2006051988A1 Method of nucleic acid amplification
05/18/2006	WO2006051986A1 Method of determining aromatase activity and determination kit therefor
05/18/2006	WO2006051951A1 REMEDY FOR DIABETES CONTAINING Cdk5 INHIBITOR
05/18/2006	WO2006051944A1 Fluorescent protein
05/18/2006	WO2006051886A1 Method of presuming the risk of worsening in autoimmune disease accompanied by dysfunction due to tissue destruction
05/18/2006	WO2006051847A1 Method of examining/judging presence of virus infection such as hiv or presence of prion infection by near-infrared spectroscopy and device used in same
05/18/2006	WO2006051670A1 Gene expression level standardization method, program, and system
05/18/2006	WO2006051548A2 Blood type method system and device
05/18/2006	WO2006051387A1 Method of producing a carnitine-synthesising micro-organism
05/18/2006	WO2006051310A1 Improved method of electrochemical analysis of an analyte
05/18/2006	WO2006051303A1 Assay for measuring an enzyme’s capability to modify supercoil topology of nucleic acids and modulators
05/18/2006	WO2006051172A1 Method for testing a compound for a therapeutic effect and a diagnostic method
05/18/2006	WO2006051088A2 Devices for carrying out and diagnosing microarray experiments
05/18/2006	WO2006050972A1 Microfluidic device with minimised ohmic resistance
05/18/2006	WO2006050945A2 Tubulin mutation diagnostic
05/18/2006	WO2006050864A1 Method for identifying methylated cytosine
05/18/2006	WO2006050611A1 Antimicrobial peptides
05/18/2006	WO2006050573A1 Method of diagnosing cancer and reagents therefor
05/18/2006	WO2006038010A3 Detection of breast cancer
05/18/2006	WO2006031273A3 Cellular phenotype
05/18/2006	WO2006021888B1 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds
05/18/2006	WO2006019954A3 In vivo assays for modulation of smad-mediated signaling
05/18/2006	WO2006013078A3 Method and kit for microbiologically identifying vitamins in substance mixtures
05/18/2006	WO2006007853A3 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
05/18/2006	WO2006005770A3 Method for the detection of fusarium graminearum
05/18/2006	WO2006003523A3 Human autism susceptibility gene encoding PRKCB1 and uses thereof
05/18/2006	WO2005123962A3 Gene targeting in eukaryotic cells by group II intron ribonucleoprotein particles
05/18/2006	WO2005123957A3 Method for nucleic acid analysis
05/18/2006	WO2005123955A3 Methods and compositions for modifying gene regulation and dna damage in ageing
05/18/2006	WO2005123760A3 Treating cancer
05/18/2006	WO2005118840A3 Diagnostics and therapeutics for diseases associated with kallikrein 10 (klk10)
05/18/2006	WO2005114188A3 Cul4 e3 ligase mediators as regulators of p53
05/18/2006	WO2005113807A3 Enhanced leak detection dye carrier
05/18/2006	WO2005113787A3 Diagnostics and therapeutics for diseases associated with g protein-dependent receptor kinase 1 (grk1)
05/18/2006	WO2005108611A3 Methods and compositions for the amplification of mutations in the diagnosis of cystic fibrosis
05/18/2006	WO2005107430A3 Internal control in situ hybridization
05/18/2006	WO2005091969B1 Pre-symptomatic markers for diseases associated with transmissible spongiform encephalopathies
05/18/2006	WO2005089268A3 Compositions and methods for optimizing cleavage of rna by rnase h
05/18/2006	WO2005087806A3 Cd38 splice variant and uses thereof
05/18/2006	WO2005054508A3 Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters
05/18/2006	WO2005054494A3 Sequence-specific inhibition of small rna function
05/18/2006	WO2005038041A3 Direct nucleic acid detection in bodily fluids
05/18/2006	WO2005035550A3 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier
05/18/2006	WO2005012544A3 Methods for the identification of inhibitors of mannosyltransferase and mannosyltransferase complex subunit as antibiotics
05/18/2006	WO2005012497A3 Translocation tagging
05/18/2006	WO2005007623A3 Inhibition of syk kinase expression
05/18/2006	WO2004074445A3 Model for studying the role of genes in tumor resistance to chemotherapy
05/18/2006	WO2004072238A3 Terminal-phosphate-labeled nucleotides with new linkers
05/18/2006	WO2004014306A3 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation

1 ... 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 ... 3003